KATP channel mutations in infants with permanent diabetes diagnosed after 6 months of life

Pediatric Diabetes

Volumn 13, Issue 4, 2012, Pages 322-325

  Rubio Cabezas, Oscar ^a,b,c   Flanagan, Sarah E ^a   Damhuis, Annet ^d   Hattersley, Andrew T ^a   Ellard, Sian ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Diabetes mellitus; Genetics; Infant; Sulfonylurea compounds

Indexed keywords

ABCC8 PROTEIN; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; GLIBENCLAMIDE; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; SULFONYLUREA DERIVATIVE; SULFONYLUREA RECEPTOR 1; UNCLASSIFIED DRUG; ABC TRANSPORTER; DRUG RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL; SULFONYLUREA RECEPTOR;

ARTICLE; CHILD; CLINICAL FEATURE; DIABETES MELLITUS; FEMALE; GENE IDENTIFICATION; GENE MUTATION; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; ONSET AGE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; TREATMENT DURATION; GENETICS;

ATP-BINDING CASSETTE TRANSPORTERS; DIABETES MELLITUS; FEMALE; HUMANS; INFANT; INSULIN; KATP CHANNELS; MALE; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; SULFONYLUREA COMPOUNDS;

EID: 84861682966     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2011.00824.x     Document Type: Article

References (14)

1. Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue KC. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2009: 10: 33-42.
2. Edghill EL, Flanagan SE, Patch AM et al. Insulin mutation screening in 1, 044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 2008: 57: 1034-1042.
3. Pearson ER, Flechtner I, Njølstad PR et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 2006: 355: 467-477.
4. Rafiq M, Flanagan SE, Patch AM et al. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 2008: 31: 204-209.
5. Mohamadi A, Clark LM, Lipkin PH, Mahone EM, Wodka EL, Plotnick LP. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM. Pediatr Diabetes 2010: 11: 203-207.
6. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006: 49: 1190-1197.
7. Gloyn AL, Pearson ER, Antcliff JF et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004: 350: 1838-1849.
8. Proks P, Arnold AL, Bruining J et al. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes. Hum Mol Genet 2006: 15: 1793-1800.
9. Porter JR, Shaw NJ, Barrett TG, Hattersley AT, Ellard S, Gloyn AL. Permanent neonatal diabetes in an Asian infant. J Pediatr 2005: 146: 131-133.
10. Massa O, Iafusco D, D'Amato E et al. KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 2005: 25: 22-27.
11. Tammaro P, Flanagan SE, Zadek B et al. A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications. Diabetologia 2008: 51: 802-810.
12. Edghill EL, Dix RJ, Flanagan SE et al. HLA genotyping supports a nonautoimmune etiology in patients diagnosed with diabetes under the age of 6 months. Diabetes 2006: 55: 1895-1898.
13. Støy J, Greeley SA, Paz VP et al. Diagnosis and treatment of neonatal diabetes: a United States experience. Pediatr Diabetes 2008: 9: 450-459.
14. Rubio-Cabezas O, Edghill EL, Argente J, Hattersley AT. Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined Type 1 diabetes. Diabet Med 2009: 26: 1070-1074.